{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:51:06Z","timestamp":1787028666190,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Diffuse alveolar haemorrhage (DAH) is a rare but potentially life-threatening pulmonary complication of systemic autoimmune diseases. Although interstitial lung disease (ILD) is a hallmark of antisynthetase syndrome (ASyS), DAH has been only exceptionally reported in this setting. Methods: We present two patients with ASyS who developed DAH confirmed by bronchoalveolar lavage. Results: The first case involved a 52-year-old woman initially diagnosed with rheumatoid arthritis, later reclassified as rheumatoid arthritis\u2013ASyS overlap, who developed DAH in the context of progressive ILD. The second case concerned a 37-year-old man with newly diagnosed ASyS who presented with recurrent DAH early in the disease course. Both patients required high-dose corticosteroids, followed by escalation of immunosuppressive therapy with rituximab or mycophenolate mofetil, resulting in clinical and radiological improvement. These cases illustrate the diagnostic challenges posed by DAH in ASyS, particularly due to overlapping features with infection and ILD exacerbation. They also highlight the importance of early bronchoscopy and timely intensification of immunosuppression. Conclusions: Increased awareness of DAH as a rare manifestation of ASyS may facilitate earlier recognition and improve outcomes in patients presenting with acute respiratory deterioration, anaemia, or haemoptysis.<\/jats:p>","DOI":"10.3390\/jcm15072555","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:12:25Z","timestamp":1774609945000},"page":"2555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse Alveolar Haemorrhage as a Rare Pulmonary Manifestation of Antisynthetase Syndrome: A Case Series"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-3348","authenticated-orcid":false,"given":"Katarzyna","family":"Kr\u00f3lak-Nowak","sequence":"first","affiliation":[{"name":"Department of General and Oncological Pulmonology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Janiak","sequence":"additional","affiliation":[{"name":"Department of General and Oncological Pulmonology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tymon","family":"Puty\u0144ski","sequence":"additional","affiliation":[{"name":"Department of General and Oncological Pulmonology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-5731","authenticated-orcid":false,"given":"Aleksandra","family":"Opinc-Rosiak","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna Samanta","family":"Makowska","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3430-3088","authenticated-orcid":false,"given":"Adam","family":"Antczak","sequence":"additional","affiliation":[{"name":"Department of General and Oncological Pulmonology, Medical University of Lodz, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3949\/ccjm.75.4.258","article-title":"Diffuse alveolar hemorrhage: Diagnosing it and finding the cause","volume":"75","author":"Ioachimescu","year":"2008","journal-title":"Cleve Clin. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4046\/trd.2013.74.4.151","article-title":"Diffuse Alveolar Hemorrhage","volume":"74","author":"Park","year":"2013","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccm.2004.04.007","article-title":"Diffuse alveolar hemorrhage","volume":"25","author":"Collard","year":"2004","journal-title":"Clin. Chest Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The Diagnosis and Treatment of Antisynthetase Syndrome","volume":"23","author":"Witt","year":"2016","journal-title":"Clin. Pulm. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: What progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J. Bras. Pneumol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Patel, P., Marinock, J.M., Ajmeri, A., and Brent, L.H. (2024). A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084453"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.21037\/jtd-20-3328","article-title":"A narrative review of interstitial lung disease in anti-synthetase syndrome: A clinical approach","volume":"13","author":"Sawal","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_10","unstructured":"(2026, February 10). The Classification Criteria for Anti-Synthetase Syndrome (Class) Project\u2014ACR Meeting Abstracts. Available online: https:\/\/acrabstracts.org\/abstract\/the-classification-criteria-for-anti-synthetase-syndrome-class-project\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: A distinct disease spectrum","volume":"5","author":"Huang","year":"2020","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3949\/ccjm.80a.12171","article-title":"Antisynthetase syndrome: Not just an inflammatory myopathy","volume":"80","author":"Chatterjee","year":"2013","journal-title":"Cleve Clin. J. Med."},{"key":"ref_13","first-page":"5453717","article-title":"Diffuse Alveolar Hemorrhage in a Patient with Antisynthetase Syndrome","volume":"2019","year":"2019","journal-title":"Case Rep. Rheumatol."},{"key":"ref_14","first-page":"3715449","article-title":"Diffuse Alveolar Hemorrhage Associated with Anti-PL-7 Antisynthetase Syndrome: A Case Report","volume":"2025","author":"Shiu","year":"2025","journal-title":"Case Rep. Pulmonol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1093\/rheumatology\/keac090","article-title":"Anti-Ro52 antibodies are associated with the prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"61","author":"Gui","year":"2022","journal-title":"Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e002076","DOI":"10.1136\/bmjresp-2023-002076","article-title":"Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: A systematic review and meta-analysis","volume":"10","author":"Nayebirad","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11926-013-0335-1","article-title":"Autoantibodies in polymyositis and dermatomyositis","volume":"15","author":"Nayebirad","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/BOR.0000000000000548","article-title":"New insights in myositis-specific autoantibodies","volume":"30","author":"Ghirardello","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semarthrit.2016.03.011","article-title":"Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group","volume":"46","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3899\/jrheum.181141","article-title":"Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies","volume":"47","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/art.41075","article-title":"Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients with Idiopathic Inflammatory Myopathies","volume":"72","author":"Albrecht","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"bcr2016217624","DOI":"10.1136\/bcr-2016-217624","article-title":"Antisynthetase syndrome (ASS) presenting as acute respiratory distress syndrome (ARDS) in a patient without myositis features","volume":"2016","author":"Kanchustambham","year":"2016","journal-title":"BMJ Case Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cavagna, L., Trallero-Aragu\u00e1s, E., Meloni, F., Cavazzana, I., Rojas-Serrano, J., Feist, E., Zanframundo, G., Morandi, V., Meyer, A., and da Silva, J.A.P. (2019). Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. J. Clin. Med., 8.","DOI":"10.3390\/jcm8112013"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/7\/2555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:22:02Z","timestamp":1774610522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/7\/2555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15072555"],"URL":"https:\/\/doi.org\/10.3390\/jcm15072555","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}